R. Kroker

731 citations
34 papers · 534 · h-index 12

Impact in

    • Drug-Induced Hepatotoxicity and Protection
    • Pharmacogenetics and Drug Metabolism
    • Antibiotics Pharmacokinetics and Efficacy
  • Oncology top 10%
    • Drug Transport and Resistance Mechanisms

Papers in

    • Drug Transport and Resistance Mechanisms 14
    • Antibiotics Pharmacokinetics and Efficacy 5
    • Drug-Induced Hepatotoxicity and Protection 4

R. Kroker

32 papers receiving 501 citations

Peers

R. Kroker
Comparison fields: 5 of 73
  • Pharmacology 124
  • Oncology 246
  • Clinical Biochemistry 51
  • Hepatology 45
  • Microbiology 31
Replace P B Hylemon with:
P B Hylemon United States
Darrell H. Mallonee United States
E Sacquet France
Shiva Bhowmik United States
X.-J. Zhao United States
Akira Niwa Japan
L Eidus Canada
Yoshiko Tomita Japan
Tsunemasa Nonogaki Japan
Niklas Finnström Sweden
R. Kroker relative to P B Hylemon United States P B Hylemon's profile →
Citations per field
00.5×7.8×
P B Hylemon · 1×
Citations per year

Countries citing papers authored by R. Kroker

Since Specialization
Citations

This map shows the geographic impact of R. Kroker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Kroker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Kroker more than expected).

Fields of papers citing papers by R. Kroker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Kroker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Kroker. The network helps show where R. Kroker may publish in the future.

Co-authors

The 25 scholars most cited alongside R. Kroker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with R. Kroker Line = papers co-authored together R. Kroker links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.

#Work
1 1976100
2 197352
3 197648
4 197842
5 197540
6 200328
7 197424
8 197824
9 197724
10
[The prevalence of antimicrobial susceptibility of veterinary pathogens isolated from cattle and pigs: national antibiotic resistance monitoring 2002/2003 of the BVL].
200517
11 199513
12 198013
13 197811
14 197811
15 197410
16 197310
17 19738
18 19858
19 19767
20 19917

About R. Kroker

R. Kroker is a scholar working on Oncology, Pharmacology, Epidemiology, Pulmonary and Respiratory Medicine and Pharmacology, having authored 34 papers that have together received 534 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (14 papers), Biochemical effects in animals (7 papers), Liver Disease Diagnosis and Treatment (6 papers), Silymarin and Mushroom Poisoning (6 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers), Metabolism and Genetic Disorders (4 papers), Drug-Induced Hepatotoxicity and Protection (4 papers) and Hepatitis B Virus Studies (2 papers). The work is most often cited by research in Pharmacology (124 citations), Oncology (246 citations), Clinical Biochemistry (51 citations), Hepatology (45 citations) and Microbiology (31 citations). R. Kroker has collaborated with scholars based in Germany. Frequent co-authors include D. Hegner, M. S. Anwer, M. Frimmer, E. Weiss, Jürgen Wallmann, Lothar H. Wieler, Heike Kaspar, Gabor Balizs, Hildburg Fry and F. R. Ungemach. Their work appears in journals such as Naunyn-Schmiedeberg s Archives of Pharmacology, Biochemical and Biophysical Research Communications, Journal of Veterinary Pharmacology and Therapeutics, Biochemical Pharmacology and International Journal of Antimicrobial Agents.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact